http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-9609013-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94975555b560b69f6fb12d1278caa76d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-044
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-04
filingDate 1996-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee75046fb2bb31f01a1adc1fb6739757
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_576fae4ff202603bd533b9524c2b7524
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f446bca363142aab0d46faaff1d7a8e
publicationDate 1999-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-9609013-A
titleOfInvention Nucleoside analog, and, compound.
abstract "ANALOGUES OF NUCLEOSìDEOS, AND, COMPOSITE". This invention relates to adenosine kinase inhibitors and nucleoside analogs, pyrrole [2,3-d] pyrimidine and pyrazol [3,4-d] pyrimidine modified nucleoside analogs, having activity as adenosine kinase inhibitors. The invention also concerns the preparation and use of these adenosine kinase inhibitors in the treatment of cardiovascular and cerebrovascular diseases, inflammation and other diseases that can be regulated by increasing the local concentration of adenosine.
priorityDate 1995-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8027
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID447916
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425914843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554679
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559203
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432787922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410031093

Total number of triples: 43.